Works matching DE "SODIUM-glucose cotransporters"
Results: 1872
SGLT2i and GLP1RA effects in patients followed in a hospital diabetology consultation.
- Published in:
- Expert Review of Clinical Pharmacology, 2024, v. 17, n. 11, p. 1081, doi. 10.1080/17512433.2024.2421872
- By:
- Publication type:
- Article
Elective peri‐operative management of adults taking glucagon‐like peptide‐1 receptor agonists, glucose‐dependent insulinotropic peptide agonists and sodium‐glucose cotransporter‐2 inhibitors: a multidisciplinary consensus statement: A consensus statement from the Association of Anaesthetists, Association of British Clinical Diabetologists, British Obesity and Metabolic Surgery Society, Centre for Perioperative Care, Joint British Diabetes Societies for Inpatient Care, Royal College of Anaesthetists, Society for Obesity and Bariatric Anaesthesia and UK Clinical Pharmacy Association
- Published in:
- Anaesthesia, 2025, v. 80, n. 4, p. 412, doi. 10.1111/anae.16541
- By:
- Publication type:
- Article
Current Advances in Optimal Medical Therapy for Heart Failure.
- Published in:
- Journal of Clinical Medicine, 2025, v. 14, n. 5, p. 1417, doi. 10.3390/jcm14051417
- By:
- Publication type:
- Article
Analysis of the Endocrine Responses to Anti-Diabetes Drugs: An Issue of Elevated Plasma Renin Concentration in Sodium-Glucose Co-Transporter 2 Inhibitor.
- Published in:
- International Journal of General Medicine, 2025, v. 18, p. 135, doi. 10.2147/IJGM.S497664
- By:
- Publication type:
- Article
EFFICACY OF SGLT-2 INHIBITORS IN THE TREATMENT OF TYPE 2 DIABETES: SINGLE CENTRE EXPERIENCE.
- Published in:
- Journal of Istanbul Faculty of Medicine / İstanbul Tıp Fakültesi Dergisi, 2025, v. 88, n. 1, p. 45, doi. 10.26650/IUITFD.1508775
- By:
- Publication type:
- Article
SGLT2 Inhibitors: The First Endothelial-Protector for Diabetic Nephropathy.
- Published in:
- Journal of Clinical Medicine, 2025, v. 14, n. 4, p. 1241, doi. 10.3390/jcm14041241
- By:
- Publication type:
- Article
Examining the results of cardiovascular outcome trials.
- Published in:
- Practice Nursing, 2019, v. 30, n. 2, p. 87, doi. 10.12968/pnur.2019.30.2.87
- By:
- Publication type:
- Article
New pharmacological approaches to diabetes management.
- Published in:
- Practice Nursing, 2015, v. 26, n. 3, p. 140, doi. 10.12968/pnur.2015.26.3.140
- By:
- Publication type:
- Article
Current updates of sodium-glucose cotransporter-2 inhibitor effects on atherosclerosis: a systematic review and meta-analysis of randomized controlled trial.
- Published in:
- Acta Angiologica, 2024, v. 30, n. 1, p. 1, doi. 10.5603/aa.98562
- By:
- Publication type:
- Article
Comment on "Comparison of Sodium-Glucose Cotransporter-2 Inhibitor and Dipeptidyl Peptidase-4 Inhibitor on the Risks of New-Onset Atrial Fibrillation, Stroke and Mortality in Diabetic Patients".
- Published in:
- Cardiovascular Drugs & Therapy, 2024, v. 38, n. 1, p. 201, doi. 10.1007/s10557-023-07527-z
- By:
- Publication type:
- Article
Comparison of Sodium-Glucose Cotransporter-2 Inhibitor and Dipeptidyl Peptidase-4 Inhibitor on the Risks of New-Onset Atrial Fibrillation, Stroke and Mortality in Diabetic Patients: A Propensity Score-Matched Study in Hong Kong.
- Published in:
- Cardiovascular Drugs & Therapy, 2023, v. 37, n. 3, p. 561, doi. 10.1007/s10557-022-07319-x
- By:
- Publication type:
- Article
Prolyl Hydroxylase Inhibitors: a New Opportunity in Renal and Myocardial Protection.
- Published in:
- Cardiovascular Drugs & Therapy, 2022, v. 36, n. 6, p. 1187, doi. 10.1007/s10557-021-07257-0
- By:
- Publication type:
- Article
Prescription Patterns of Sodium-Glucose Cotransporter 2 Inhibitors and Cardiovascular Outcomes in Patients with Diabetes Mellitus and Heart Failure.
- Published in:
- Cardiovascular Drugs & Therapy, 2022, v. 36, n. 3, p. 497, doi. 10.1007/s10557-021-07234-7
- By:
- Publication type:
- Article
Protection of the kidney with sodium-glucose cotransporter 2 inhibitors: potential mechanisms raised by the large-scaled randomized control trials.
- Published in:
- Clinical & Experimental Nephrology, 2019, v. 23, n. 3, p. 304, doi. 10.1007/s10157-018-1673-0
- By:
- Publication type:
- Article
Comparison between sodium‐glucose cotransporter 2 inhibitors and dipeptidyl peptidase 4 inhibitors on the risk of incident cancer in patients with diabetes mellitus: A real‐world evidence study.
- Published in:
- Diabetes/Metabolism Research & Reviews, 2024, v. 40, n. 3, p. 1, doi. 10.1002/dmrr.3784
- By:
- Publication type:
- Article
A meta‐analysis of randomized controlled trials evaluating sodium‐glucose co‐transporter 2 inhibitors and incidental atrial fibrillation—Is there a true benefit?
- Published in:
- Diabetes/Metabolism Research & Reviews, 2024, v. 40, n. 1, p. 1, doi. 10.1002/dmrr.3715
- By:
- Publication type:
- Article
Dapagliflozin improves pancreatic islet function by attenuating microvascular endothelial dysfunction in type 2 diabetes.
- Published in:
- Diabetes/Metabolism Research & Reviews, 2023, v. 39, n. 3, p. 1, doi. 10.1002/dmrr.3607
- By:
- Publication type:
- Article
Effects of sodium‐glucose co‐transporter 2 inhibitors on liver parameters and steatosis: A meta‐analysis of randomized clinical trials.
- Published in:
- Diabetes/Metabolism Research & Reviews, 2021, v. 37, n. 6, p. 1, doi. 10.1002/dmrr.3413
- By:
- Publication type:
- Article
Managing type 2 diabetes mellitus during COVID‐19 pandemic: The bittersweet.
- Published in:
- Diabetes/Metabolism Research & Reviews, 2021, v. 37, n. 1, p. 1, doi. 10.1002/dmrr.3360
- By:
- Publication type:
- Article
Poor adherence and persistence to sodium glucose co‐transporter 2 inhibitors in real‐world settings: Evidence from a systematic review and meta‐analysis.
- Published in:
- Diabetes/Metabolism Research & Reviews, 2021, v. 37, n. 1, p. 1, doi. 10.1002/dmrr.3350
- By:
- Publication type:
- Article
Long-term renal outcomes associated with sodium glucose cotransporter 2 inhibitors in patients with type 2 diabetes mellitus: A systematic review and meta-analysis.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Meta-analysis on the efficacy and safety of SGLT2 inhibitors and incretin based agents combination therapy vs. SGLT2i alone or add-on to metformin in type 2 diabetes.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Effects of sodium-glucose cotransporter 2 inhibitors on risk of venous thromboembolism in patients with type 2 diabetes: A systematic review and meta-analysis.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Effects of SGLT2 inhibitors on fractures and bone mineral density in type 2 diabetes: An updated meta-analysis.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Mechanistic evaluation of the effect of sodium‐dependent glucose transporter 2 inhibitors on delayed glucose absorption in patients with type 2 diabetes mellitus using a quantitative systems pharmacology model of human systemic glucose dynamics.
- Published in:
- Biopharmaceutics & Drug Disposition, 2020, v. 41, n. 8/9, p. 352, doi. 10.1002/bdd.2253
- By:
- Publication type:
- Article
The Na/K-ATPase Signaling and SGLT2 Inhibitor-Mediated Cardiorenal Protection: A Crossed Road?
- Published in:
- Journal of Membrane Biology, 2021, v. 254, n. 5/6, p. 513, doi. 10.1007/s00232-021-00192-z
- By:
- Publication type:
- Article
De Novo Expression of Sodium-Glucose Cotransporter SGLT2 in Bowman's Capsule Coincides with Replacement of Parietal Epithelial Cell Layer with Proximal Tubule-like Epithelium.
- Published in:
- Journal of Membrane Biology, 2014, v. 247, n. 8, p. 675, doi. 10.1007/s00232-014-9686-4
- By:
- Publication type:
- Article
Effect of SGLT2 Inhibitors on Risk of Stroke in Diabetes: A Meta-Analysis.
- Published in:
- Cerebrovascular Diseases, 2022, v. 51, n. 5, p. 585, doi. 10.1159/000521782
- By:
- Publication type:
- Article
Forxiga (dapagliflozin): Plausible role in the treatment of diabetes-associated neurological disorders.
- Published in:
- Biotechnology & Applied Biochemistry, 2016, v. 63, n. 1, p. 145, doi. 10.1002/bab.1319
- By:
- Publication type:
- Article
Sodium glucose cotransporter 2 in mesangial cells and retinal pericytes and its implications for diabetic nephropathy and retinopathy.
- Published in:
- Glycobiology, 2017, v. 27, n. 8, p. 691, doi. 10.1093/glycob/cwx047
- By:
- Publication type:
- Article
Predictors Of Kidney Function Outcomes In Type 2 Diabetes Mellitus Patients With Chronic Heart Failure Treated With Dapagliflosin.
- Published in:
- E Journal of Cardiovascular Medicine, 2023, v. 11, p. 1
- By:
- Publication type:
- Article
Potential impact of sodium glucose co-transporter (SGLT2) inhibitors on cholesterol fractions in stage 3 chronic kidney disease.
- Published in:
- Egyptian Journal of Internal Medicine, 2024, v. 36, n. 1, p. 1, doi. 10.1186/s43162-024-00352-2
- By:
- Publication type:
- Article
SGLT2 inhibitors: Indications, doses and licences (England, Scotland and Wales).
- Published in:
- Diabetes & Primary Care, 2021, v. 23, n. 6, p. 175
- Publication type:
- Article
Drugs in development and new data on established drugs: Highlights from the American Diabetes Association 81st Scientific Sessions.
- Published in:
- Diabetes & Primary Care, 2021, v. 23, n. 4, p. 115
- Publication type:
- Article
News from the Diabetes UK Professional Conference 2021. Part 1.
- Published in:
- Diabetes & Primary Care, 2021, v. 23, n. 3, p. 75
- Publication type:
- Article
HOW TO USE SGLT2 INHIBITORS SAFELY AND EFFECTIVELY.
- Published in:
- Diabetes & Primary Care, 2021, v. 23, n. 1, p. 5
- Publication type:
- Article
Smoking and COVID-19: Unravelling the risks and signposting resources.
- Published in:
- Diabetes & Primary Care, 2021, v. 23, n. 1, p. 1
- By:
- Publication type:
- Article
News from the 2020 EASD Annual Meeting.
- Published in:
- Diabetes & Primary Care, 2020, v. 22, n. 5, p. 115
- By:
- Publication type:
- Article
A disease state approach to the pharmacological management of Type 2 diabetes in primary care: A position statement by Primary Care Diabetes Europe.
- Published in:
- Diabetes & Primary Care, 2020, v. 22, n. 3, p. 1
- By:
- Publication type:
- Article
Ketones and diabetes.
- Published in:
- Diabetes & Primary Care, 2020, v. 22, n. 3, p. 49
- Publication type:
- Article
SGLT2 inhibitors and their association with balanoposthitis and Fournier's gangrene.
- Published in:
- Diabetes & Primary Care, 2020, v. 22, n. 2, p. 31
- By:
- Publication type:
- Article
The management of hyperglycaemia in people with diabetes and chronic kidney disease: A GPnotebook Shortcut.
- Published in:
- Diabetes & Primary Care, 2020, v. 22, n. 1, p. 13
- Publication type:
- Article
Diabetes and kidney disease. Part 2: management.
- Published in:
- Diabetes & Primary Care, 2019, v. 21, n. 5, p. 153
- By:
- Publication type:
- Article
The 2019 ESC/EASD guidelines: Comprehensive and controversial.
- Published in:
- Diabetes & Primary Care, 2019, v. 21, n. 5, p. 145
- By:
- Publication type:
- Article
Why NICE needs to change: Defining a new prescribing pathway.
- Published in:
- Diabetes & Primary Care, 2019, v. 21, n. 1, p. 33
- By:
- Publication type:
- Article
HOW TO USE SGLT2 INHIBITORS SAFELY.
- Published in:
- Diabetes & Primary Care, 2018, v. 20, n. 5, p. 173
- Publication type:
- Article
ADA/EASD DRAFT CONSENSUS GUIDELINE.
- Published in:
- Diabetes & Primary Care, 2018, v. 20, n. 3, p. 105
- Publication type:
- Article
OBSERVE-4D.
- Published in:
- Diabetes & Primary Care, 2018, v. 20, n. 3, p. 102
- By:
- Publication type:
- Article
The SIGN 154 diabetes guideline and primary care: it's not just about the glucose.
- Published in:
- Diabetes & Primary Care, 2018, v. 20, n. 2, p. 75
- By:
- Publication type:
- Article
Sodium--glucose cotransporter 2 inhibitors: Emerging evidence and changes in guidance.
- Published in:
- Diabetes & Primary Care, 2017, v. 19, n. 5, p. 210
- By:
- Publication type:
- Article